Europe Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over the Counter Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Ner
Description
Europe Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over the Counter Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Nervous System, Genito-urinary, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and by Country/Region (Germany, France, U.K., Italy, Spain, Russia, The Netherlands, Poland, Switzerland, Sweden, and Rest of Europe) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Pharmaceutical drugs are composed of chemical compounds which are used for prevention and treatment of diseases and are administered intravenously, orally, intramuscularly, and other routes of administration. Pharmaceutical drugs are of two types; generic and branded. Pharmaceutical drugs are subjected to numerous regulations with respect to patenting, clinical trial, drug safety, efficacy and marketing in European region.
Market Dynamics
Patent expiry of branded products is paving the entry for generics drugs in the market. Moreover, product launches along with increasing healthcare expenditure are major factors that are driving the global Europe pharmaceutical drugs market growth.
For instance, Cetuximab (Erbitux) is an epidermal growth factor receptor inhibitor indicated for the treatment of metastatic colorectal cancer and head and neck cancer. It is manufactured under the patent by Bristol-Myers Squibb and Eli Lily Company in Europe. The drug’s patent expires in 2021, and thus, is expected to provide opportunity for a large number of market players to manufacture generic versions.
Furthermore, adoption of inorganic and organic strategies such as mergers and acquisitions, and product developments by key players to expand their product portfolio is expected to drive the market growth. For instance, on January 2020, Novartis AG received European Commission’s approval for MAyznet for treatment of secondary progressive multiple sclerosis (SPMS) in adult patients.
Key features of the study:
This report provides in-depth analysis of the Europe Pharmaceutical Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Europe Pharmaceutical Drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Allergan plc. , Novo Nordisk, Boehringer Ingelheim, Merck KGaA, GlaxoSmithKline Plc. , AstraZeneca Plc, Baxter AG, Novartis AG, F. Hoffmann-La Roche Ltd, Shire, and Sanofi
Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global Europe Pharmaceutical Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Europe Pharmaceutical Drugs market
Detailed Segmentation:
Europe Pharmaceutical Drugs Market, By Drug Type:
Generic Drugs
Branded Drugs
Global Europe Pharmaceutical Drugs Market, By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
Global Europe Pharmaceutical Drugs Market, By Application:
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
Global Europe Pharmaceutical Drugs Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Europe Pharmaceutical Drugs Market, By Country/Region:
U.K.
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Germany
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
France
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Italy
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Spain
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Russia
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Netherlands
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Poland
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Switzerland
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Sweden
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Rest of Europe
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Company Profiles
Allergan plc. *
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Novo Nordisk
Boehringer Ingelheim
Merck KGaA
GlaxoSmithKline Plc.
AstraZeneca Plc
Baxter AG
Novartis AG
F. Hoffmann-La Roche Ltd
Shire
Sanofi
“*” marked represents similar segmentation in other categories in the respective section.
Pharmaceutical drugs are composed of chemical compounds which are used for prevention and treatment of diseases and are administered intravenously, orally, intramuscularly, and other routes of administration. Pharmaceutical drugs are of two types; generic and branded. Pharmaceutical drugs are subjected to numerous regulations with respect to patenting, clinical trial, drug safety, efficacy and marketing in European region.
Market Dynamics
Patent expiry of branded products is paving the entry for generics drugs in the market. Moreover, product launches along with increasing healthcare expenditure are major factors that are driving the global Europe pharmaceutical drugs market growth.
For instance, Cetuximab (Erbitux) is an epidermal growth factor receptor inhibitor indicated for the treatment of metastatic colorectal cancer and head and neck cancer. It is manufactured under the patent by Bristol-Myers Squibb and Eli Lily Company in Europe. The drug’s patent expires in 2021, and thus, is expected to provide opportunity for a large number of market players to manufacture generic versions.
Furthermore, adoption of inorganic and organic strategies such as mergers and acquisitions, and product developments by key players to expand their product portfolio is expected to drive the market growth. For instance, on January 2020, Novartis AG received European Commission’s approval for MAyznet for treatment of secondary progressive multiple sclerosis (SPMS) in adult patients.
Key features of the study:
This report provides in-depth analysis of the Europe Pharmaceutical Drugs market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global Europe Pharmaceutical Drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Allergan plc. , Novo Nordisk, Boehringer Ingelheim, Merck KGaA, GlaxoSmithKline Plc. , AstraZeneca Plc, Baxter AG, Novartis AG, F. Hoffmann-La Roche Ltd, Shire, and Sanofi
Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global Europe Pharmaceutical Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Europe Pharmaceutical Drugs market
Detailed Segmentation:
Europe Pharmaceutical Drugs Market, By Drug Type:
Generic Drugs
Branded Drugs
Global Europe Pharmaceutical Drugs Market, By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
Global Europe Pharmaceutical Drugs Market, By Application:
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
Global Europe Pharmaceutical Drugs Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Europe Pharmaceutical Drugs Market, By Country/Region:
U.K.
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Germany
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
France
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Italy
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Spain
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Russia
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Netherlands
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Poland
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Switzerland
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Sweden
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Rest of Europe
By Drug Type:
Generic Drugs
Branded Drugs
By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
By Application
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Company Profiles
Allergan plc. *
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Novo Nordisk
Boehringer Ingelheim
Merck KGaA
GlaxoSmithKline Plc.
AstraZeneca Plc
Baxter AG
Novartis AG
F. Hoffmann-La Roche Ltd
Shire
Sanofi
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
199 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Country/Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Industry Trends
- Regulatory Scenario
- Reimbursement Scenario
- Epidemiology
- PEST Analysis
- 4. Europe Pharmaceutical Drugs Market, By Drug Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Generic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Branded Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 5. Europe Pharmaceutical Drugs Market, By Product Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Over-the-counter (OTC) Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 6. Europe Pharmaceutical Drugs Market, By Application, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Metabolic Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Central Nervous System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Genito-urinary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 7. Europe Pharmaceutical Drugs Market, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 8. Europe Pharmaceutical Drugs Market, By Country, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- U.K.
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Germany
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- France
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Italy
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Spain
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Russia
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Netherlands
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Poland
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Switzerland
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Sweden
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- Rest of Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
- 9. Competitive Landscape
- Company Profiles
- Allergan plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novo Nordisk
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boehringer Ingelheim
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- GlaxoSmithKline Plc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca Plc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Shire
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 10. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 30 market data tables and 38 figures on "Pharmaceutical Drugs Market - Europe forecast to 2028”.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
